Back to AssetMark, Inc. AssetMark, Inc.

MRNAMRNA

Showing 9 of 22 quarters

Position history for AssetMark, Inc.AssetMark, Inc.'s holdings in Moderna, Inc.

Yes. AssetMark holds 912 shares of MRNA (Moderna), worth $175,598, as of its Q3 2026 13F filing. It increased the position by 114 shares (+14.3%) from Q2 2026. AssetMark has held MRNA since Q2 2021, across 22 quarterly 13F filings.

Current Value

$175,598

Current Shares

912

Total Value Change

+$160,194

Total Shares Change

+681

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
912
+14.3%
$175,5980.0%$192.57
26
2026-Q2
Decreased
798
-0.4%
$55,8750.0%$70.03
0
2026-Q1
Increased
801
+35.1%
$40,7030.0%$50.80
26
2025-Q4
Decreased
593
-47.2%
$17,4730.0%$29.49
0
2025-Q3
Decreased
1,124
-13.4%
$29,0200.0%$25.83
0
2025-Q2
Increased
1,298
+137.7%
$35,7980.0%$27.59
32
2025-Q1
Increased
546
+48.8%
$15,4650.0%$28.35
17
2024-Q4
Increased
367
+58.9%
$15,2390.0%$41.58
18
2024-Q3
Decreased
231
-99.5%
$15,4040.0%$65.75
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used